1. Zydus Lifesciences
stock logo

38% Hold

Zydus Lifesciences Share Price

ZYDUSLIFE

₹1,113.20+₹9.05 (0.82%) TodayLast updated on 10 Sep, 2024 | 15:57 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • Events

  • F&O (Option chain)

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹1,10,686 Crs

Open

₹1,109.00

Close

₹1,104.15

Circuit range

₹1,214.55 - ₹993.75

Day range

₹1,108.00 - ₹1,120.85

Year range

₹567.75 - ₹1,324.30

Volume

10,10,547

Avg. traded

₹1,112.85

Revenue (12m)

₹20,615 Crs

Zydus LifesciencesZydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Zydus Lifesciences Key indicators

arrow

52 week high

₹1,324.30

52 week low

₹567.75

P/E ratio

26.65

P/B ratio

5.2

ROE

23.45%

ROCE

22.95%

Dividend yield

0.27%

Debt/Equity ratio

0.39

EPS

34.21

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

31%

Hold

38%

Sell

31%

This analysis is based on the reviews of 26 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

47.51%

Net profit margin

31.79%

ROE

23.45%

ROA

13.61%

ROCE

22.95%

Learn more

Zydus Lifesciences Shareholder returns

arrow

1 day

+0.38%

1 week

-0.67%

1 month

-15.12%

3 months

+4.58%

1 year

+75.78%

3 years

+97.84%

5 years

+367.27%

Zydus Lifesciences Share Price history

arrow
DayOpenCloseDay’s change
Mon, Sep 9 2024
₹1,100.00
₹1,104.15
+0.38%
Fri, Sep 6 2024
₹1,118.85
₹1,100.00
-1.36%
Thu, Sep 5 2024
₹1,127.95
₹1,115.15
-1.13%
Wed, Sep 4 2024
₹1,112.20
₹1,127.90
+1.25%
Tue, Sep 3 2024
₹1,115.60
₹1,114.00
+0.22%
Mon, Sep 2 2024
₹1,127.00
₹1,111.55
-1.45%
Fri, Aug 30 2024
₹1,139.90
₹1,127.90
-0.37%
Thu, Aug 29 2024
₹1,138.30
₹1,132.05
-0.55%

Shareholding info

arrow

Promoters (74.98%)

Mutual Funds (7.24%)

Retail and other (6.79%)

Foreign institutions-FII (5.59%)

Other domestic institutions (5.39%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹3/share

    Ex date 26 Jul 2024

    expand tab
  • Dividend • ₹6/share

    Ex date 28 Jul 2023

    expand tab
  • Dividend • ₹2.5/share

    Ex date 28 Jul 2022

    expand tab
  • Dividend • ₹0/share

    Ex date

    expand tab

Learn more

Frequently asked questions